Palavras-chave
Como Citar
Resumo
This study was designed to compare the effectiveness of the R5-ELISA and immunochromatographic assays in detecting gluten in foods labeled gluten-free and to determine if the immunochromatographic method is a sensitive and reliable method for detecting gluten at safe levels for celiac patients. We analyzed seventy different commercially foods available in Brazil, labeled “gluten-free”. Gluten was extracted by ethanol precipitation and, subsequently, analyzed using a commercial immunochromatographic test and ELISA kit, both based in a monoclonal antibody. The analysis of sensitivity and specificity was made using the kappa coefficient. More than a quarter of the samples (28.6%) analyzed by ELISA contained levels of gluten greater than 5 mg/kg. Almost half of these (12.9%) exhibited levels that exceeded 20 mg/kg, the maximum gluten level recommended by the Codex Alimentarius for a naturally gluten-free product. We found 27.1% of the samples tested positive in the immunochromatographic test. There was no statistically significant difference between the results of the ELISA (detection value ≥ 5 mg/kg) and the immunochromatographic test. Comparing the ELISA (≥ 5 mg/kg) and immunochromatographic test, we obtained 90% sensitivity and 98% specificity (Kappa of 0.89). We found gluten in a high proportion of the samples tested using both methods. In this study we also demonstrate that the immunochromatographic method is nearly as sensitive as the ELISA in detecting gluten levels and thus may serve as an inexpensive and rapid alternative to the R5-ELISA screening test.Referências
O'Leary C, Wieneke P, Healy M, Cronin C, O'Regan P, Shanahan F. Celiac disease and the transition from childhood to adulthood: A 28-year follow-up. Am J Gastroenterol. 2004;99(12):2437-41.
Rostom A, Murray JA, Kagnoff MF. American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease. Gastroenterology. 2006;131(6):1981-2002.
Schubert-Ullrich P, Rudolf J, Ansari P, Galler B, Fährer M, Molinelli A, Baumgartner S. Commercialized rapid immunoanalytical tests for determination of allergenic food proteins: An overview. Anal Bioanal Chem. 2009;395(1):69-81.
Green PHR. Where are all those patients with celiac disease? Am J Gastroenterol. 2007;102(7):1461-3.
Maki M, Mustalahti K, Kokkonen J, Kulmala P, Haapalahti M, Karttunen T, et al. Prevalence of Celiac disease among children in Finland. N Engl J Med. 2003;348(25):2517-24.
Tommasini A, Not T, Kiren V, Baldas V, Santon D, Trevisiol C, et al. Mass screening for coeliac disease using antihuman transglutaminase antibody assay. Arch Dis Child. 2004;89(6):512-5.
Fasano A, Berti I, Gerarduzzi T, Not T, Colletti RB, Drago S, et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Int Med. 2003;163(3):286-92.
Brandt KG, Silva GA. [Seroprevalence of celiac disease at a general pediatric outpatient clinic]. Arq Gastroenterol. 2008;45(3):239-42.
Gandolfi L, Pratesi R, Cordoba JCM, Tauil PL, Gasparin M, Catassi C. Prevalence of celiac disease among blood donors in Brazil. Am J Gastroenterol. 2000;95(3):689-92.
Rodrigo L, Garrote JA, Vivas S. [Celiac disease]. Med Clin. 2008;131(7):264-70.
Almeida PL, Gandolfi L, Modelli IC, Martins RC, Almeida RC, Pratesi R. Prevalence of celiac disease among first degree relatives of Brazilian celiac patients. Arqu Gastroenterol. 2008;45(1):69-72.
Wieser H. Chemistry of gluten proteins. Food Microbiol. 2007;24(2):115-9.
Hischenhuber C, Crevel R, Jarry B, Maki M, Moneret-Vautrin DA, Romano A, et al. Review article: safe amounts of gluten for patients with wheat allergy or coeliac disease. Aliment Pharmacol Ther. 2006;23(5):559-75.
Valdés I, Garcia E, Llorente M, Mendez E. Innovative approach to low-level gluten determination in foods using a novel sandwich enzyme-linked immunosorbent assay protocol. Eur J Gastroenterol Hepatol. 2003;15(5):465-74.
Shewry PR, Halford NG, Belton PS, Tatham AS. The structure and properties of gluten: An elastic protein from wheat grain. Philos Trans R Soc Lond B Biol Sci. 2002;357(1418):133-42.
van den Broeck HC, America AHP, Smulders MJM, Bosch D, Hamer RJ, Gilissen LJWJ, et al. A modified extraction protocol enables detection and quantification of celiac disease-related gluten proteins from wheat. J Chromatogr B Analyt Technol Biomed Life Sci. 2009;877(10):975-82.
Kasarda DD. The Grain. Greenbelt: Department of health and human services food and drug administration center for food safety and applied nutrition 2005:85-90 [cited 2009 Aug. 12]. Available from: http://www.docstoc.com/docs/14023186/1-DEPARTMENT-OF-HEALTH-AND-HUMAN-SERVICES-FOOD-AND-DRUG
Jabri B, Kasarda DD, Green PHR. Innate and adaptive immunity: The Yin and Yang of celiac disease. Immunol Rev. 2005;206:219-31.
Abreu RW, Barbosa SFC, Torre JCMD, Lichtig J, Zenebon O. Detecção de glúten em alimentos por meio de ELISA. Rev Inst Adolfo Lutz. 2007;3(65):176-80.
Hirayama KB. Assessment of gluten in homemade foods prepared by celiac disease patients and/or their caretakers [tese]. São Paulo: Universidade Federal de São Paulo; 2007.
Altman DG. Pratical statistics for medical research. London: Chapman & Hall; 1991.
Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159-74.
Codex Alimentarius. Standard for Foods for Special Dietary use for Persons Intolerant to Gluten. Vol 4. Rome: Italy; 2008.
Brasil. Lei nº 8543, de 23 de dezembro de 1992. Determina a impressão de advertência em rótulos e embalagens de alimentos industrializados que contenham glúten a fim de evitar a doença celíaca ou síndrome celíaca. Diário Oficial da União, Brasília, 24 dez. 1992. Seção 1, p. 7.
Brasil. Agência Nacional de Vigilância Sanitária. Resolução RDC nº 40, de 08 de fevereiro de 2002. Regulamento Técnico para Rotulagem de alimentos e bebidas embalados que contenham glúten. Diário Oficial da União, Brasília, 13 fev. 2002. Seção 1, p. 34.
Brasil. Lei nº 10.674, de 16 de maio de 2003. Obriga a que todos os produtos alimentícios informem sobre a presença de glúten, como medida preventiva de controle da doença celíaca. Diário Oficial da União, Brasília, 16 maio 2003. Seção 1, p. 1.
Kahlenberg F, Sanchez D, Lachmann I, Tuckova L, Tlaskalova H, Mendez E, et al. Monoclonal antibody R5 for detection of putatively coeliac-toxic gliadin peptides. Eur Food Res Technol. 2006;222(1-2):78-82.
Osman AA, Uhlig HH, Valdes I, Amin M, Méndez E, Mothes T. A monoclonal antibody that recognizes a potential coeliac-toxic repetitive pentapeptide epitope in gliadins. Eur J Gastroenterol Hepatol. 2001;13(10):1189-93.
Mendez E, Vela C, Immer U, Janssen FW. Report of a collaborative trial to investigate the performance of the R5 enzyme linked immunoassay to determine gliadin in gluten-free food. Eur J Gastroenterol Hepatol. 2005;17(10):1053-63.
Wieser H, Koehler P. The Biochemical Basis of Celiac Disease. Cereal Chem. 2008;85(1):1-13.
Doña VV, Fossati CA, Chirdo FG. Interference of denaturing and reducing agents on the antigen/antibody interaction. Impact on the performance of quantitative immunoassays in gliadin analysis. Eur Food Rese Technol. 2008;226(3):591-602.
Garcia E, Llorente M, Hernando A, Kieffer R, Wieser H, Mendez E. Development of a general procedure for complete extraction of gliadins for heat processed and unheated foods. Eur J Gastroenterol Hepatol. 2005;17(5):529-39.
A revista Segurança Alimentar e Nutricional utiliza a licença do Creative Commons (CC), preservando assim, a integridade dos artigos em ambiente de acesso aberto.
Downloads
